Department of Gastroenterology, 900th Hospital of Joint Logistics Support Force, Fujian Medical University, Fuzhou, China.
Department of Gastroenterology, 900th Hospital of Joint Logistics Support Force, People's Liberation Army, Fuzhou, China.
Scand J Gastroenterol. 2022 Nov;57(11):1374-1380. doi: 10.1080/00365521.2022.2085061. Epub 2022 Jun 14.
To evaluate the value and compare the effectiveness of linked color imaging-based endoscopic grading of gastric intestinal metaplasia (LCI-EGGIM) and operative link on gastric intestinal metaplasia (OLGIM) in risk stratification of early gastric cancer (EGC).
Eighty-one patients with EGC who underwent endoscopic submucosal dissection were included. The general data and EGC-related risk factors of all participants were recorded. LCI-EGGIM and OLGIM were used for both groups.
The number of patients with LCI-EGGIM score ≥ 5 was significantly higher in the EGC group than in the control group (58.02% vs. 12.35%, < .001). Furthermore, the number of patients with OLGIM stage III/IV in the EGC group was significantly higher than that in the control group (56.79% vs. 7.41%, < .001). Multivariate analysis showed that OLGIM stage III/IV (adjusted odds ratio [AOR]: 29.74, 95% CI: 7.49-117.94) and LCI-EGGIM score ≥ 5 (AOR: 12.33, 95% CI: 3.71-41.02) were significantly associated with EGC. There was no significant difference in the area under the receiver operating characteristic curve between LCI-EGGIM and OLGIM in predicting the risk of EGC (0.74 vs. 0.77, = .1116).
OLGIM and LCI-EGGIM can be used and have the same value for predicting the risk stratification of EGC in patients with gastric intestinal metaplasia.
评估基于链接颜色成像的胃肠上皮化生内镜分级(LCI-EGGIM)与胃肠上皮化生操作链接(OLGIM)在早期胃癌(EGC)风险分层中的价值,并比较其效果。
纳入 81 例行内镜黏膜下剥离术的 EGC 患者。记录所有患者的一般资料和 EGC 相关危险因素。对两组患者均采用 LCI-EGGIM 和 OLGIM 进行评估。
EGC 组的 LCI-EGGIM 评分≥5 的患者数量明显多于对照组(58.02%比 12.35%, < .001)。此外,EGC 组的 OLGIM Ⅲ/Ⅳ期患者数量明显多于对照组(56.79%比 7.41%, < .001)。多因素分析显示,OLGIM Ⅲ/Ⅳ期(调整优势比 [AOR]:29.74,95%置信区间:7.49-117.94)和 LCI-EGGIM 评分≥5(AOR:12.33,95%置信区间:3.71-41.02)与 EGC 显著相关。LCI-EGGIM 和 OLGIM 预测 EGC 风险的受试者工作特征曲线下面积无显著差异(0.74 比 0.77, = .1116)。
OLGIM 和 LCI-EGGIM 可用于预测胃肠上皮化生患者 EGC 的风险分层,且具有相同的价值。